ALDX
Price:
$1.61
Market Cap:
$97.12M
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, includi...[Read more]
Industry
Biotechnology
IPO Date
2014-05-02
Stock Exchange
NASDAQ
Ticker
ALDX
According to Aldeyra The’s latest financial reports and current stock price. The company's current Enterprise Value is 47.63M. This represents a change of -75.70% compared to the average of 195.98M of the last 4 quarters.
The mean historical Enterprise Value of Aldeyra The over the last ten years is 144.49M. The current 47.63M Enterprise Value has changed 3.20% with respect to the historical average. Over the past ten years (40 quarters), ALDX's Enterprise Value was at its highest in in the March 2023 quarter at 434.88M. The Enterprise Value was at its lowest in in the December 2021 quarter at 18.14M.
Average
144.49M
Median
130.24M
Minimum
2.24M
Maximum
278.17M
Discovering the peaks and valleys of Aldeyra The Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.34%
Maximum Annual Enterprise Value = 278.17M
Minimum Annual Increase = -98.69%
Minimum Annual Enterprise Value = 2.24M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 256.58M | -0.40% |
| 2024 | 257.61M | 223.12% |
| 2023 | 79.72M | -71.34% |
| 2022 | 278.17M | 12.34% |
| 2021 | 2.24M | -98.69% |
| 2020 | 170.48M | 33.34% |
| 2019 | 127.85M | -3.61% |
| 2018 | 132.64M | 48.06% |
| 2017 | 89.58M | 79.04% |
| 2016 | 50.03M | 10.75% |
The current Enterprise Value of Aldeyra The (ALDX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
197.97M
5-year avg
174.86M
10-year avg
144.49M
Aldeyra The’s Enterprise Value is less than AC Immune S.A. (173.50M), greater than Mereo BioPharma Group plc (12.70M), less than Silence Therapeutics plc (540.03M), less than Cellectis S.A. (256.09M), less than Genelux Corporation (120.12M), less than Contineum Therapeutics, Inc. (524.41M), less than Alto Neuroscience, Inc. (679.64M), less than Amarin Corporation plc (154.57M), less than Candel Therapeutics, Inc. (495.70M), less than Kyverna Therapeutics, Inc. (431.38M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 173.50M | $231.03M | |
| 12.70M | $48.92M | |
| 540.03M | $545.55M | |
| 256.09M | $287.19M | |
| 120.12M | $126.90M | |
| 524.41M | $537.62M | |
| 679.64M | $937.71M | |
| 154.57M | $292.87M | |
| 495.70M | $688.74M | |
| 431.38M | $429.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aldeyra The using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aldeyra The or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Aldeyra The's Enterprise Value?
What is the highest Enterprise Value for Aldeyra The (ALDX)?
What is the 3-year average Enterprise Value for Aldeyra The (ALDX)?
What is the 5-year average Enterprise Value for Aldeyra The (ALDX)?
How does the current Enterprise Value for Aldeyra The (ALDX) compare to its historical average?